• Publications
  • Influence
Suppression of testicular androgenesis by D-tryptophan-6-luteinizing hormone-releasing hormone does not affect TSH secretion in male subjects.
Basal and TRH-stimulated TSH secretion was evaluated in patients suffering from prostatic cancer, before and after antiandrogenic treatment performed using a long-acting LHRH analogue, D-Trp-6-LHRH, to suggest that pharmacological castration does not affect the regulatory mechanisms involved in the control of T SH secretion. Expand
Treatment of prostatic cancer with a depot form of a luteinizing hormone-releasing hormone analogue.
Chronic administration of a depot form of D-Trp6 luteinizing hormone-releasing hormone (LH-RH), an LH-RH analogue, to 14 patients with locally extended or metastatic cancer of the prostate provided a good degree of disease control and induced a sharp and long-lasting inhibition of both gonadotropin and testosterone secretion. Expand
A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
Results show that the percentage of recoveries of clinical symptoms and of bacterial eradications were significantly higher, and associated with a lower rate of side effects in the patients treated by cephemic cofosfolactamine than in those treating by cephalexin or fosfomycin. Expand
[Comparative evaluation of the effects of intravenous administration of cimetidine and ranitidine on several cardiovascular parameters].
Intravenous administration of cimetidine and ranetidine did not induce any significant alterations in cardiovascular variables. Expand